XTX Topco’s Beam Therapeutics BEAM Stock Holding History

XTX Topco’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.57M	Sell	45,755 -6,306	-12%	-$190K	0.02%	1353
2026 Q1	$1.24M	Buy	52,061 +36,704	+239%	+$1.02M	0.02%	1232
2025 Q4	$426K	Buy	+15,357	New	+$392K	0.01%	1756
2024 Q4	–	Sell	-37,001	Closed	-$907K	–	2301
2024 Q3	$907K	Buy	37,001 +5,191	+16%	+$134K	0.07%	469
2024 Q2	$745K	Buy	+31,810	New	+$781K	0.06%	473
2023 Q4	–	Sell	-23,404	Closed	-$563K	–	1604
2023 Q3	$563K	Buy	23,404 +14,625	+167%	+$392K	0.1%	331
2023 Q2	$280K	Buy	8,779 +1,517	+21%	+$49.2K	0.05%	767
2023 Q1	$222K	Buy	+7,262	New	+$287K	0.05%	878
2022 Q4	–	Sell	-4,524	Closed	-$216K	–	1133
2022 Q3	$216K	Buy	+4,524	New	+$258K	0.05%	732

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

XTX Topco's BEAM Position: Q2 2026 in Review

XTX Topco reduced its Beam Therapeutics (BEAM) stake by 12% in Q2 2026, selling an estimated $190K and leaving 45,755 shares worth $1.57M. The position accounts for 0.02% of the portfolio, ranked #1353.

XTX Topco first reported a position in BEAM in Q3 2022 and has held it in 9 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

XTX Topco held 45,755 shares of Beam Therapeutics worth $1.57M as of Q2 2026.
XTX Topco sold 6,306 Beam Therapeutics shares in Q2 2026, an estimated $190K.
Beam Therapeutics made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1353 holding.
XTX Topco first reported a position in Beam Therapeutics in Q3 2022 and has held it in 9 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.